ライフサイエンスコーパス: day post partum

1 estation, and at the post-partum visit (0-14 days post partum).

2 was early infant mortality (deaths until 90 days post partum).

3 d by pregnancy but significantly decreased 1 day post-partum.

4 a peripheral vein on the same day and second day post-partum.

5 spermine than spermidine, except for the 5th day post-partum.

6 eaching levels up to 4.41 mumol/l on the 3rd day post-partum.

7 cted at the 1st, 2nd, 3rd, 4th, 5th and 15th day post-partum.

8 related with age in hours over the first few days post partum.

9 aken daily, every month from enrolment to 90 days post partum.

10 women were enrolled a mean (+/-SD) of 16+/-2 days post partum.

11 alization and 20 weeks' gestation through 42 days post partum.

12 to women who received Tdap vaccine within 14 days post partum.

13 t partum, occurring a mean (SD) of 12.5 (14) days post partum.

14 and SUD-related PPR at 42, 90, 180, and 365 days post partum.

15 ospitalization during pregnancy or within 42 days post partum.

16 0 days, less than 90 days, and less than 180 days post partum.

17 mortality, arising between conception and 42 days post partum.

18 h to 42 days post partum, and from 43 to 365 days post partum.

19 the second birth hospitalization or up to 42 days post partum.

20 variation in effective contraceptive use 60 days post partum.

21 proteasome were restored to normal levels 7 days post-partum.

22 inal abnormalities and died between 7 and 21 days post-partum.

23 Sardinian ewes were enrolled between 7 +/- 3 days post-partum.

24 in in the catchment area for follow-up of 28 days post-partum.

25 rbidity (SMM) from 20 weeks' gestation to 42 days' post partum.

26 death after 16 weeks' gestation and before 7 days post partum; 0.86 [0.74-1.00], p=0.039), early pret

27 expulsion was highest for insertions 0 to 3 days post partum (10.73%; 95% CI, 9.12%-12.61%) and lowe

28 sured separately for the prenatal period, 60 days post partum, 12 months post partum, and the full pe

29 late (E17-19, 173.7 %) fetal and neonatal (1 day post partum, 161 %) TG+ compared with transgenic neg

30 At 42 days post partum, a major depressive episode was observe

31 m and all-cause neonatal mortality within 28 days post-partum among babies who survived the first 24

32 Plasma samples were obtained 10 days post partum and analyzed for resistance mutations.

33 Timely follow-up in the immediate days post partum and continued long-term follow-up shoul

34 natal depression scale score at seven and 42 days post partum and the 17 item Hamilton depression rat

35 were all-cause neonatal mortality within 28 days post-partum and all-cause neonatal mortality within

36 ion, the hyaloid vessels are persistent at 8 days post-partum and the retinal vasculature overgrows.

37 aternal morbidity (in pregnancy and up to 42 days' post partum) and severe neonatal morbidity (up to

38 death arising in pregnancy, from birth to 42 days post partum, and from 43 to 365 days post partum.

39 than 80% enrollment through pregnancy to 60 days post partum; and (3) evidence of coverage for depre

40 ode in the prenatal period; 1.14%, within 60 days post partum; and 3.31%, within 12 months post partu

41 d from 183 days prior to delivery through 28 days post partum (baseline).

42 th decreases major depressive episodes at 42 days post partum by about three quarters.

43 ing at any point from date of delivery to 42 days post partum (described as SMM).

44 evalence of a major depressive episode at 42 days post partum, diagnosed using the mini-international

45 Transcription ceases in the ovary by 3 days post partum (dpp), but continues in the testis thro

46 partum for preintervention vs 7.0 [6.0-10.5] days post partum for postintervention; P = .001).

47 f readmission (median [IQR] 10.0 [10.0-11.0] days post partum for preintervention vs 7.0 [6.0-10.5] d

48 were detectable in blood samples obtained 10 days post partum from 32 percent of the women who had re

49 At 1 day post-partum, lactationally active, distended lobuloa

50 hen the follow-up period was shortened to 42 days post partum or the delivery hospitalization.

51 n mice immediately after birth (P0) or at 10 days post partum (P10) to determine whether neural respo

52 trus stage, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7).

53 P), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7).

54 By 5 days post-partum, prominent expression became restricted

55 Hamilton depression rating scale score at 42 days post partum (range 0-52, with higher scores indicat

56 It makes the case for WHO to extend the 42-day post-partum threshold to capture the full duration o

57 Extending the WHO 42-day post-partum threshold up to 4 months would increase

58 luate the empirical justification for the 42-day post-partum threshold.

59 m ranged from 2.73 (95% CI 1.33-5.63; 0 to 3 days post partum) to 6.71 (4.80-9.38; 4 days to <=6 week

60 amilton depression rating scale scores at 42 days post partum were also lower in the esketamine group

61 aths occurring during pregnancy and up to 42 days post partum were defined as pregnancy related.

62 During farm visits, cows within 21 days post-partum were categorized in one of three clinic

63 blood transfusion by hospital discharge or 7 days post partum, whichever came first.